Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Govoni

Showing results (101-110 of 254) with videos related to

Pageof 26
Sort By:
Clinical and Experimental Rheumatology|May 19, 2017
Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational studyRoberto Caporali, Luca Idolazzi, Stefano Bombardieri, et al.
Arthritis Care & Research|January 28, 2016
Development and First Validation of a Disease Activity Score for GoutCarlo A Scirè, Greta Carrara, Cinzia Viroli, et al.
Arthritis Research & Therapy|January 11, 2020
Correction to: Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian expertsSerena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|June 20, 2015
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar yearsFlorenzo Iannone, Fausto Salaffi, Antonio Marchesoni, et al.
Arthritis Research & Therapy|December 13, 2019
Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian expertsSerena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, et al.
Microorganisms|March 26, 2022
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering AutoimmunityDaria Bortolotti, Valentina Gentili, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experimentLuca Quartuccio, Matteo Piga, Fabiola Atzeni, et al.
Frontiers in Immunology|June 25, 2021
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy SubjectsChiara Mazziotta, Carmen Lanzillotti, Elena Torreggiani, et al.
Clinical and Experimental Rheumatology|June 29, 2023
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus surveyAnnamaria Iagnocco, Francesco Ciccia, Fabrizio Conti, et al.
Internal Medicine Journal|October 30, 2019
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective studyAndreina Manfredi, Giulia Cassone, Federica Furini, et al.
Pageof 26

Showing results (101-110 of 254) with videos related to

Sort By:
Pageof 26
Clinical and Experimental Rheumatology|May 19, 2017
Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational studyRoberto Caporali, Luca Idolazzi, Stefano Bombardieri, et al.
Arthritis Care & Research|January 28, 2016
Development and First Validation of a Disease Activity Score for GoutCarlo A Scirè, Greta Carrara, Cinzia Viroli, et al.
Arthritis Research & Therapy|January 11, 2020
Correction to: Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian expertsSerena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|June 20, 2015
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar yearsFlorenzo Iannone, Fausto Salaffi, Antonio Marchesoni, et al.
Arthritis Research & Therapy|December 13, 2019
Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian expertsSerena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, et al.
Microorganisms|March 26, 2022
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering AutoimmunityDaria Bortolotti, Valentina Gentili, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experimentLuca Quartuccio, Matteo Piga, Fabiola Atzeni, et al.
Frontiers in Immunology|June 25, 2021
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy SubjectsChiara Mazziotta, Carmen Lanzillotti, Elena Torreggiani, et al.
Clinical and Experimental Rheumatology|June 29, 2023
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus surveyAnnamaria Iagnocco, Francesco Ciccia, Fabrizio Conti, et al.
Internal Medicine Journal|October 30, 2019
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective studyAndreina Manfredi, Giulia Cassone, Federica Furini, et al.
Pageof 26